Clinical trial
Ground-Breaking Electroporation-based Intervention for PERSistent Atrial Fibrillation Treatment (BEAT PERS-AF)
NCT05418725 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ground-Breaking Electroporation-based Intervention for PERSistent Atrial Fibrillation Treatment (BEAT PERS-AF)
- Lead sponsor
- University Hospital, Bordeaux
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 4, 2022
- Completion date
- May 28, 2025
- Enrollment
- 83 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.